Grifols (GRFS)
Create an Alert
26.45
-0.01 -0.04%
NASDAQ
Jun 19, 11:49AM
BATS Real time
Currency in USD
Grifols Cash from Operations Quarterly:
118.39M for March 31, 2013Grifols Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 118.39M |
| Dec. 31, 2012 | 222.35M |
| Sept. 30, 2012 | 182.71M |
| June 30, 2012 | 160.65M |
| March 31, 2012 | 106.25M |
| Dec. 31, 2011 | 202.81M |
| Sept. 30, 2011 | 58.55M |
| June 30, 2011 | -37.62M |
| March 31, 2011 | 61.59M |
| June 30, 2010 | 148.51M |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
GRFS Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | -12.51M |
| ARCA biopharma | -0.764M |
| Clinuvel Pharmaceuticals |
GRFS Cash from Operations Quarterly Rankings
| Overall |
93rd percentile 1045 of 16782 |
| Sector |
94th percentile 72 of 1410 in Healthcare |
| Industry |
98th percentile 9 of 454 in Biotechnology |
GRFS Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -37.62M | Jun 2011 |
| Maximum | 222.35M | Dec 2012 |
| Average | 122.42M |
